Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc (Nasdaq: PAVM) that has breakthrough devices, EsoCheck and EsoGuard, for esophageal cell collection and diagnosis of Barrett's Esophagus.    

Medical Devices

Lucid Diagnostics

Lucid Diagnostics' headquarters in New York, NY, United States

Lishan Aklog

Shaun O'Neil

Dennis M. Mcgrath

Nick Shaheen

Gary Falk

Sandy Markowitz

Anthony Infantolino

Amitabh Chak

Michael Smith

Stan Lapidus

Prateek Sharma

Joe Willis

Sri Komanduri

Jacque J. Sokolov

The Sales and Client Services team at Lucid Diagnostics is responsible for driving revenue through strategic sales initiatives and providing exceptional support to healthcare professionals and clients. This team collaborates closely to educate potential customers about Lucid's innovative diagnostic solutions, ensuring seamless onboarding and ongoing support to maximize client satisfaction and retention. By leveraging expertise in the field, the team aims to expand market reach and foster strong relationships within the healthcare industry.

Sales and Client Services

The Regulatory and Compliance team at Lucid Diagnostics is responsible for ensuring that all products, including EsoCheck and EsoGuard, meet the necessary regulatory standards and compliance guidelines set forth by healthcare authorities. This team collaborates with various stakeholders, including legal, scientific, and medical experts, to navigate the complex landscape of medical device approval and maintain adherence to safety and efficacy protocols throughout the development and marketing processes.

Regulatory and Compliance

The Research and Laboratory Operations team at Lucid Diagnostics is dedicated to advancing the development and validation of innovative diagnostic devices for esophageal health. Comprised of experts in research, clinical laboratory science, and product development, the team conducts rigorous testing and analysis to ensure the efficacy and reliability of EsoCheck and EsoGuard. They play a crucial role in driving clinical research initiatives, overseeing laboratory operations, and enhancing diagnostic methodologies to improve patient outcomes in the detection of Barrett's Esophagus.

Research and Laboratory Operations

The Leadership Team at Lucid Diagnostics is responsible for setting the strategic direction of the company, overseeing the development and commercialization of its innovative diagnostic devices, EsoCheck and EsoGuard. This team ensures alignment across all departments, including clinical research, financial management, and market strategies, to drive the mission of improving early detection and diagnosis of Barrett's Esophagus.

Lucid Diagnostics

Org chart

Board & advisors

Teams

Sales and Client Services

Regulatory and Compliance

Research and Laboratory Operations

Leadership Team

Offices

Lucid Diagnostics

Org chart

Board & advisors

Teams

Sales and Client Services

Regulatory and Compliance

Research and Laboratory Operations

Leadership Team

Offices

Related companies